Dr Gina Jiang is the Managing Director of Hong Kong Institute of Biotechnology, an affiliate of the Chinese University of Hong Kong, where she leads the establishment of patient-centred cell therapy manufacturing and the expansion of the institute’s existing GMP capacity.

A medical entrepreneur that sits at the intersection of medicine, design, and technology, Dr Jiang has built a number of MedTech start-ups in Silicon Valley and Taipei, including FGMi (丰聚醫創) that collaborates with hospitals to create solutions based on patient experience and social determinants.